| Literature DB >> 32456323 |
Emma Griffiths1,2, Julia V Marley1,2, David Atkinson1.
Abstract
Preconception care (PCC) is acknowledged as a vital preventive health measure aiming to promote health today and for subsequent generations. We aimed to describe the content and context of PCC delivery in a very remote Australian Aboriginal Community Controlled Health Service setting. A retrospective audit was undertaken to identify what PCC was delivered between 2011 and 2018 to 127 Aboriginal women who had at least one pregnancy during this period. Of 177 confirmed pregnancies, 121 had received PCC prior to the pregnancy. Sexually transmissible infection screening (71%) was the most common care delivered, followed by folic acid prescription (57%) and smoking cessation support (43%). Younger women received PCC less often, particularly screening for modifiable pregnancy risk factors. Rates of prediabetes/diabetes, albuminuria, overweight/obesity and smoking were high amongst those screened (48-60%). PCC was usually patient-initiated and increased significantly over the audit period. Presentation for antenatal care in the first trimester of pregnancy was high at 73%. Opportunities to increase PCC delivery include integration with routine health checks, pregnancy tests and chronic disease programs. PCC programs codesigned with young people are also recommended. All primary care providers should be supported and assisted to provide opportunistic PCC and health promotion.Entities:
Keywords: aboriginal health; preconception; preventive care; primary care; reproductive health
Year: 2020 PMID: 32456323 PMCID: PMC7277238 DOI: 10.3390/ijerph17103702
Source DB: PubMed Journal: Int J Environ Res Public Health ISSN: 1660-4601 Impact factor: 3.390
Figure 1Search strategy applied to identify women with confirmed pregnancies and the preconception care they received (audit period 1 January 2011–1 September 2018).
Characteristics of confirmed pregnancies, by preconception care (PCC) group (n = 177).
| n | Received PCC | Did Not Receive PCC | Logistic Regression |
| |
|---|---|---|---|---|---|
| n (%) | n (%) | OR (95% CI) | |||
| Age at first antenatal visit: | |||||
| 15–19 years | 35 | 22 (18) | 13 (23) | 0.66 (0.27–1.60) | 0.35 |
| 20–24 years | 68 | 49 (41) | 19 (34) | 1 λ | |
| 25–29 years | 33 | 24 (20) | 9 (16) | 1.03 (0.39–2.73) | 0.95 |
| 30–34 years | 23 | 17 (14) | 6 (11) | 1.10 (0.38–3.21) | 0.86 |
| 35 years and over | 18 | 9 (7) | 9 (16) | 0.39 (0.11–1.41) | 0.15 |
| Pregnancy outcome: | |||||
| Live birth | 141 | 95 (78) | 46 (82) | 1 λ | |
| Miscarriage | 28 | 19 (16) | 9 (16) | 1.02 (0.32–3.24) | 0.97 |
| Other * | 8 | 7 (6) | 1 (2) | 3.39 (0.40–28.98) | 0.27 |
| Gestation at first antenatal visit: | |||||
| Unknown # | 34 | 25 (20) | 9 (16) | 1.27 (0.39–4.09) | 0.69 |
| <6 weeks | 38 | 30 (25) | 8 (14) | 1.71 (0.66–4.44) | 0.27 |
| 6–12 weeks | 67 | 46 (38) | 21 (38) | 1 λ | |
| 12–24 weeks | 26 | 13 (11) | 13 (23) | 0.46 (0.18–1.17) | 0.10 |
| 24–36 weeks | 12 | 7 (6) | 5 (9) | 0.64 (0.19–2.18) | 0.48 |
| Parity prior: | |||||
| 0 | 56 | 39 (32) | 17 (30) | 1 λ | |
| 1 | 53 | 38 (32) | 15 (27) | 1.10 (0.49–2.48) | 0.81 |
| 2 | 30 | 21 (17) | 9 (16) | 1.02 (0.41–2.54) | 0.97 |
| 3 | 18 | 13 (11) | 5 (9) | 1.13 (0.35–3.64) | 0.83 |
| 4 and greater | 20 | 10 (8) | 10 (18) | 0.44 (0.13–1.48) | 0.18 |
| Diabetes status preconception (by HbA1c (mmol/mol) or care plan allocated): | |||||
| Unknown (no result) | 98 | 64 (53) | 34 (61) | n.a. | |
| Normal (<5.7%) | 41 | 30 (25) | 11 (19) | 1 λ | |
| Prediabetes (5.7–6.4%) | 13 | 11 (9) | 2 (4) | 2.02 (0.37–10.86) | 0.41 |
| Diabetes (≥6.5%) | 25 | 16 (13) | 9 (16) | 0.65 (0.21–2.00) | 0.45 |
| Albuminuria status preconception (by albumin: creatinine ratio (mg/mmol) or care plan allocated): | |||||
| Unknown (no result) | 76 | 53 (44) | 23 (41) | n.a. | |
| Normal (<3.0) | 58 | 38 (31) | 20 (36) | 1 λ | |
| Elevated (≥3.0) | 43 | 30 (25) | 13 (23) | 1.21 (0.52–2.81) | 0.65 |
| BMI preconception (kg/m2): | |||||
| Unknown (no result) | 97 | 61 (50) | 36 (65) | n.a. | |
| <18.5 | 20 | 13 (11) | 7 (12) | 0.44 (0.12–1.65) | 0.23 |
| 18.5–25 | 26 | 21 (17) | 5 (9) | 1 λ | |
| 25–30 | 18 | 13 (11) | 5 (9) | 0.62 (0.13–2.93) | 0.55 |
| >30 | 16 | 13 (11) | 3 (5) | 1.03 (0.21–5.14) | 0.97 |
| Smoking behaviour preconception: | |||||
| Unknown (no record) | 102 | 67 (55) | 35 (63) | n.a. | |
| Current smoker | 45 | 35 (29) | 10 (18) | 1 λ | |
| Ex-smoker | 10 | 6 (5) | 4 (7) | 0.43 (0.11–1.60) | 0.21 |
| Never smoked | 20 | 13 (11) | 7 (12) | 0.53 (0.13–2.13) | 0.37 |
| TOTAL | 121 (100) | 56 (100) | |||
* Includes termination of pregnancy (n = 1), ectopic pregnancy (n = 2), and pregnancies ongoing at census date (n = 5). # Includes termination of pregnancy (n = 1), miscarriages (n = 25), ectopic pregnancy (n = 2) or pregnancies lost to follow up or where no estimated delivery date was recorded (n = 6). λ Largest group used as reference group for logistic regression (generalized estimating equations, adjusted for correlations within the same woman, for a binomial family using the logit link function). n.a. = not applicable.
Characteristics of preconception care delivered.
| Reason for Presentation, by Consultation (n = 579): | n (%) |
|---|---|
| Requesting pregnancy test | 163 (28) |
| Requesting cessation of contraception | 135 (23) |
| Unwell or other unrelated health concern | 114 (20) |
| Preconception care | 70 (12) |
| Sexual health | 30 (5) |
| Chronic disease management or scheduled health check | 29 (5) |
| Multiple reasons | 21 (4) |
| Requesting check-up | 17 (3) |
| Designation of staff member/s, by consultation (n = 579): | |
| Nurse or Aboriginal health worker only | 343 (59) |
| General practitioner * and nurse or Aboriginal health worker | 111 (19) |
| General practitioner * only | 98 (17) |
| Midwife | 22 (4) |
| Other | 5 (1) |
| Components of care delivered, by pregnancy (n = 121) **: | |
| Sexually transmissible infections | 86 (71) |
| Folic acid | 69 (57) |
| Smoking cessation and avoidance | 52 (43) |
| Nutrition and weight | 44 (36) |
| Alcohol and illicit substances | 31 (26) |
| Chronic disease management | 20 (17) |
| Vaccinations | 14 (12) |
* General practitioner includes registrars (doctors completing general practice training). ** Number (%) of pregnancies receiving care, does not sum to 100%.
Preconception care (PCC) over time.
| Year | Pregnancies, Total (n) | “Received PCC” Pregnancies (n (%)) | Of Those Receiving Care: Components of PCC Delivered, by Pregnancy (Median) | ||
|---|---|---|---|---|---|
| Number of Key Components ** | Number of Times *** | Number of Consultations | |||
| 2011 | 13 | 8 (53) | 2.5 | 3 | 2.5 |
| 2012 | 29 | 18 (58) | 1 | 1 | 3 |
| 2013 | 26 | 17 (52) | 3 | 3 | 3 |
| 2014 | 22 | 13 (57) | 2 | 3 | 2 |
| 2015 | 37 | 24 (60) | 3 | 4 | 4 |
| 2016 | 18 | 14 (74) | 3 | 4 | 3.5 |
| 2017 | 23 | 18 (70) | 3.5 | 5.5 | 5.5 |
| 2018 | 11 * | 9 (75) | 4 | 7 | 5 |
| Total | 177 | 121 (100) | |||
|
| 0.105 | 0.044 | 0.003 | ||
* Incomplete year, inclusive of 1 January 2018–1 September 1 2018, excluded from trend analysis. ** Key components (n = 7): folic acid supplementation, nutrition and weight assessment, smoking cessation, alcohol and illicit substances, chronic diseases, vaccinations, sexually transmissible infections. *** Total includes multiple counts if topics were addressed more than once, e.g., repeat folic acid provision was counted twice. # Postestimation following generalized estimating equations, adjusted for correlations within the same woman, for a normal family was used to determine if there was a linear trend for care provision over time.
Key components of preconception care included in audit tool [11,12].
| Component | Royal Australian College of General Practitioners Recommendations [ | Criteria Used to Count Care in Audit (Any of the Following): |
|---|---|---|
|
| ||
| Folic acid supplementation | Most women: 0.5 mg/day supplementation, beginning ideally at least one month prior to conception and continuing for the first trimester. High-risk women: 5 mg/day supplementation. | Prescription of and/or dispensing of supply of folic acid (with or without iodine or iron); explanation of indication and support with adherence. |
| Nutrition and weight assessment | Nutritional assessment and appropriate intervention with an emphasis on optimising maternal body mass index (BMI) and micronutrient reserves. | Advice re. impact of weight and nutrition on conception and pregnancy; support to improve diet, weight and activity levels for healthy pregnancy. |
| Smoking cessation | Inform women who smoke that tobacco affects fetal growth and advise them to stop smoking. | Advice re. impact of use in pregnancy and support with cessation; prescription of nicotine replacement therapy, with reference to healthy pregnancy. |
| Alcohol and illicit drug use | Advise that not drinking is the safest option; illicit drugs may harm the fetus, advise them to avoid use. | Level of use documented; advice re. impact of use in pregnancy and support with cessation. |
| Chronic diseases | Optimise control of existing chronic diseases (e.g., diabetes, hypertension, epilepsy). Avoid teratogenic medications. | Management of chronic disease for healthy pregnancy. |
| Vaccinations | MMR; varicella (in those without a clear history of chickenpox or who are non-immune on testing); influenza; diphtheria; tetanus; acellular pertussis. | Collection of pathology to determine immune status; administration of relevant vaccine. |
| Sexually transmissible infections (STI) * | Screening for STI and/or treatment for healthy pregnancy; advice re. regular testing, impact of STI in pregnancy, STI prevention. | |
|
| ||
| Psychosocial health | Discuss perinatal mental health conditions, psychological or psychiatric assessment and treatment, use of medication and the risk of exacerbation of mood disorders in pregnancy and postpartum. Mental health screening should include a psychosocial assessment. | Family and domestic violence OR mental health discussed, documented or assessed using formal tool; advice re. impact of use in pregnancy; brief intervention or referral to support agencies. |
| Cervical screening | Completion of cervical screening or pap smear. | |
| Advice regarding normal reproduction and conception | Advice re. timing of ovulation and positive pregnancy tests; fertile periods; signs and symptoms of early pregnancy. | |
* Regional priority due to syphilis outbreak and high background rates of other sexually transmissible infections [54].